From the beginning of the covid-19 pandemic, we have already tested approx. 2,500 patients as part of various research projects.

Despite the ongoing Covid-19 pandemic at the BRG facility, we are still active and with ongoing projects. We maintain constant contact with our patients who are open to participation in new research. In order to maintain appropriate prophylaxis and safety of the conducted projects we perform according to the highest standards, using instructions and procedures of the Ministry of Health, Sanitary-epidemiological station, WHO (World Health Organization) and EMA (European Medicines Agency).

We have already tested approximately 2,500 patients as part of various research projects. The safety of patients is supervised by qualified nurses, laboratory technicians, pharmacists and coordinators as well as recognized medical experts with many years of experience and knowledge. This confirm that our site is effective and efficient and able to provide rapid study start-up for trials research of various therapies even in challenging environment.

Go back

News

Privacy Policy introduced on 25th of May 2018

On May 25, 2018, the European Union will begin to enforce more strict privacy rules under the General Data Protection Regulation (GDPR), so we have introduced new Privacy Policy.

Read more …

International Clinical Trials Day on 24th of May 2018

Our Team has participated in one of the most importants conferences regarding Clinical Trials in Poland.

Read more …

New article about EMA guidelines on FIH studies

In "Scientific Publications" tab you can find an interesting, new article about update of EMA guideline on strategies to identify and mitigate risks for first-in-human clinical trials

Read more …

Easter Wishes

To all our Sponsors, Vendors, Employees and Co-Workers we wish joy and happiness for the in-coming Easter!

Read more …

Annual GCP training

On 24th of March, 2018 we have organized the second annual GCP training for all our employees and co-workers.

Read more …

About Us | Services | Our Site | Partners | Smoking Risk Study | Contact Us

Early Phase Clinical Trials

2024 © Bio Research Group. All rights reserved.

 

scroll to top ▲